(Q40852837)

24 September 2017

title

Interleukin-12 and perforin mRNA expression is augmented in blood mononuclear cells in multiple sclerosis (English)

1 reference

24 September 2017

0 references

Matusevicius D

1

1 reference

24 September 2017

Kivisäkk P

2

1 reference

24 September 2017

Navikas V

3

1 reference

24 September 2017

Söderström M

4

1 reference

24 September 2017

Fredrikson S

5

1 reference

24 September 2017

Link H

6

1 reference

24 September 2017

publication date

1 June 1998

1 reference

Scandinavian Journal of Immunology

24 September 2017

published in

1 reference

24 September 2017

volume

47

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

582-590

1 reference

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Lymphokine production by human T cells in disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Perforin: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Molecular cloning and chromosomal assignment of a human perforin (PFP) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

Cytotoxicity of T cells for cerebral endothelium in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00344.X

10.1046/J.1365-3083.1998.00344.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference